Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06429644
Status:
COMPLETED
Last Update Posted:
2024-05-28
First Post:
2024-04-30
Brief Title:
Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA12 Mutations
Sponsor:
Hanyang University Seoul Hospital
Organization:
Hanyang University Seoul Hospital
Study Overview
Official Title:
Ong-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA12 Mutations
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The investigators matched BCS and mastectomy group using propensity scores and analyzed the recurrence and survival among the evenly matched patients in breast cancer patients with BRCA 12 mutations
Detailed Description:
The purpose of study is to assess the oncologic safety of BCS in patients carrying BRCA12 mutations by comparing long-term outcomes with mastectomy The investigators matched BCS and mastectomy group using propensity scores and analyzed the recurrence and survival among the evenly matched patients By providing insights into the feasibility of BCS for patients with BRCA12 mutations the investigators aim to present evidence to aid in surgical decision-making for the care of these patients
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None